Contact Us

MEETING NEWS

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

Dec 18, 2024

YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme

Internet celeb videos fuel Hainan travel popularity surge

Dec 18, 2024

HAIKOU,China,Dec. 12,2024--A report fromHainan International Media Center (HIMC): This year,as Hainan\'s visa free policy continued to broaden easy access to the island province in south China,the num

Mirae Asset Bolsters Suite of Fixed Income ETFs with its Global X US Treasury 0-3 Month ETF

Dec 18, 2024

TheGlobal X US Treasury 0-3 Month ETF (3440 / 9440)is the first short-term US T-bills ETF listed in Hong Kong

Xinhua Silk Road: AI Expo opens in E. China's Suzhou Industrial Park to bolster high-tech growth drivers

Dec 18, 2024

BEIJING,Dec. 13,2024-- The 2024 Global AI Product & Application Expo,a 2-day event showcasing the latest AI technologies and products,kicked off in Suzhou Industrial Park (SIP) on Tuesday.

Midea Strengthens Global Presence in the Heat Pump Industry with Optimistic Market Outlook

Dec 18, 2024

FOSHAN,China,Dec. 13,2024-- In a recent exclusive interview withJARN,a leading Japanese HVAC industry publication,Peter Guan,Vice President of Midea Group and President of Midea Building Technologies

Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS

Dec 18, 2024

PRINCETON,N.J. and SUZHOU,China,Dec. 13,2024-- Transcenta Holding Limited ("Transcenta") (HKEX: 06628),a global clinical stage biopharmaceutical company with fully-integrated capabilities in

1 ... 168 169 170 171 172 173 174 ... 348